GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Microport Endovascular Medtech Co Ltd (SHSE:688016) » Definitions » ROCE %

Shanghai Microport Endovascular Medtech Co (SHSE:688016) ROCE % : 21.46% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Microport Endovascular Medtech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Microport Endovascular Medtech Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 21.46%.


Shanghai Microport Endovascular Medtech Co ROCE % Historical Data

The historical data trend for Shanghai Microport Endovascular Medtech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Microport Endovascular Medtech Co ROCE % Chart

Shanghai Microport Endovascular Medtech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial 24.04 21.14 25.35 24.47 20.00

Shanghai Microport Endovascular Medtech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.10 37.55 25.49 16.19 21.46

Shanghai Microport Endovascular Medtech Co ROCE % Calculation

Shanghai Microport Endovascular Medtech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=574.089/( ( (1995.119 - 186.835) + (4246.209 - 312.765) )/ 2 )
=574.089/( (1808.284+3933.444)/ 2 )
=574.089/2870.864
=20.00 %

Shanghai Microport Endovascular Medtech Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=868.816/( ( (4246.209 - 312.765) + (4524.505 - 360.503) )/ 2 )
=868.816/( ( 3933.444 + 4164.002 )/ 2 )
=868.816/4048.723
=21.46 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Microport Endovascular Medtech Co  (SHSE:688016) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Shanghai Microport Endovascular Medtech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai Microport Endovascular Medtech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Microport Endovascular Medtech Co (SHSE:688016) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 201318
Shanghai Microport Endovascular Medtech Co Ltd is primarily engaged in the development, production and sales of medical devices for aortic and peripheral vascular interventions.

Shanghai Microport Endovascular Medtech Co (SHSE:688016) Headlines

No Headlines